Paper Details
- Home
- Paper Details
Use of Tox21 Screening Data to Evaluate the COVID-19 Drug Candidates for Their Potential Toxic Effects and Related Pathways.
Author: HuangRuili, SakamuruSrilatha, XiaMenghang
Original Abstract of the Article :
Currently, various potential therapeutic agents for coronavirus disease-2019 (COVID-19), a global pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), are being investigated worldwide mainly through the drug repurposing approach. Several anti-viral, anti-bacterial, an...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9333127/
データ提供:米国国立医学図書館(NLM)
Assessing COVID-19 Drug Candidates for Potential Toxicity
This study explores the potential toxic effects of various drug candidates being investigated for the treatment of COVID-19. The researchers utilized a comprehensive dataset of in vitro assay results from the Tox21 program, which screened thousands of compounds, including approved drugs and environmental chemicals, against multiple cellular targets and pathways. The study analyzed the toxicological profiles of drug candidates currently under clinical trials for COVID-19, identifying potential toxic effects and associated pathways. The study highlights the importance of early toxicity assessment in drug development, particularly for repurposed drugs, which may have unanticipated side effects.Toxicity Screening for COVID-19 Treatments
This study underscores the importance of comprehensive toxicity screening during the development of new drugs for COVID-19. The findings highlight the potential for repurposed drugs to have unanticipated side effects and emphasize the need for careful evaluation of drug candidates before clinical use.Navigating Pandemics: A Camel's Perspective on Safety
As a camel, I've learned to be cautious in harsh environments. The COVID-19 pandemic, much like a desert storm, has brought its own challenges. This study highlights the importance of careful evaluation and safety assessment when seeking new treatments, ensuring that potential benefits outweigh any risks.Dr.Camel's Conclusion
This study underscores the importance of early toxicity assessment in the development of new drugs for COVID-19, particularly for repurposed drugs. The findings highlight the potential for unanticipated side effects and emphasize the need for careful evaluation of drug candidates before clinical use.Date :
- Date Completed n.d.
- Date Revised 2022-08-02
Further Info :
Related Literature
Article Analysis
SNS
PICO Info
in preparation
Languages
English
Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.